TrialHuman vaccines & immunotherapeutics2023

Phase III randomized clinical studies to evaluate the immunogenicity, lot-to-lot consistency, and safety of ROTAVAC® liquid formulations (ROTAVAC 5C & 5D) and non-inferiority comparisons with licensed ROTAVAC® (frozen formulation) in healthy infants.

Krishna Kumari P et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.